245 related articles for article (PubMed ID: 23827477)
1. Non-alcoholic steatohepatitis: a microbiota-driven disease.
Moschen AR; Kaser S; Tilg H
Trends Endocrinol Metab; 2013 Nov; 24(11):537-45. PubMed ID: 23827477
[TBL] [Abstract][Full Text] [Related]
2. Obesity and NAFLD: the role of bacteria and microbiota.
Duseja A; Chawla YK
Clin Liver Dis; 2014 Feb; 18(1):59-71. PubMed ID: 24274865
[TBL] [Abstract][Full Text] [Related]
3. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
Larter CZ; Chitturi S; Heydet D; Farrell GC
J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
[TBL] [Abstract][Full Text] [Related]
4. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance.
Parnell JA; Raman M; Rioux KP; Reimer RA
Liver Int; 2012 May; 32(5):701-11. PubMed ID: 22221818
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and non-alcoholic fatty liver disease: new insights.
Aron-Wisnewsky J; Gaborit B; Dutour A; Clement K
Clin Microbiol Infect; 2013 Apr; 19(4):338-48. PubMed ID: 23452163
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease.
Coulon S; Francque S; Colle I; Verrijken A; Blomme B; Heindryckx F; De Munter S; Prawitt J; Caron S; Staels B; Van Vlierberghe H; Van Gaal L; Geerts A
Cytokine; 2012 Aug; 59(2):442-9. PubMed ID: 22658783
[TBL] [Abstract][Full Text] [Related]
7. The role of cytokines in non-alcoholic fatty liver disease.
Tilg H
Dig Dis; 2010; 28(1):179-85. PubMed ID: 20460908
[TBL] [Abstract][Full Text] [Related]
8. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatohepatitis in children.
Nanda K
Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
[TBL] [Abstract][Full Text] [Related]
10. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies.
Frasinariu OE; Ceccarelli S; Alisi A; Moraru E; Nobili V
Dig Liver Dis; 2013 Jul; 45(7):543-51. PubMed ID: 23280158
[TBL] [Abstract][Full Text] [Related]
11. [The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease].
Orlik B; Handzlik G; Olszanecka-Glinianowicz M
Postepy Hig Med Dosw (Online); 2010 May; 64():212-9. PubMed ID: 20498498
[TBL] [Abstract][Full Text] [Related]
12. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.
Asrih M; Jornayvaz FR
J Endocrinol; 2013 Sep; 218(3):R25-36. PubMed ID: 23833274
[TBL] [Abstract][Full Text] [Related]
13. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
14. [Non-alcoholic fatty liver].
Tagle Arrospide M
Rev Gastroenterol Peru; 2003; 23(1):49-57. PubMed ID: 12768215
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
16. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic steatohepatitis and metabolic syndrome.
Machado M; Cortez-Pinto H
Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
[TBL] [Abstract][Full Text] [Related]
19. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
20. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
